CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Yahoo! Finance
BRISBANE, Calif., January 12, 2026 BUSINESS WIRE )--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today reported preliminary, unaudited financial results for the fourth quarter and full year 2025. Preliminary Fourth Quarter 2025 Financial Results Revenue of approximately $108 million, an increase of 25% year-over-year Testing services revenue of approximately $78 million, an increase of 23% year-over-year Testing services volume of approximately 53,000, an increase of 17% year-over-year Average revenue per test of approximately $1,470 including approximately $5 million in prior period revenue Patient & digital solutions revenue of approximately $17 million, an increase of 47% year-over-year Product revenue of approximately $13 million, an increase of 17% year-over-
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial ResultsBusiness Wire
- CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response [Yahoo! Finance]Yahoo! Finance
- CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug ResponseBusiness Wire
- CareDx (NASDAQ:CDNA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating.MarketBeat
- CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
CDNA
Earnings
- 11/4/25 - Beat
CDNA
Sec Filings
- 1/15/26 - Form 144
- 1/12/26 - Form 8-K
- 1/7/26 - Form 4
- CDNA's page on the SEC website